| ASSET | MONTH | % RETURN |
|---|---|---|
Immunovant (IMVT) | October 2022 | 97.53% |
Spyre Therapeutics (SYRE) | October 2022 | 94.34% |
Nuvalent (NUVL) | October 2022 | 82.57% |
Vaxcyte (PCVX) | October 2022 | 78% |
ADEIA (ADEA) | October 2022 | 68.12% |
Oceaneering International (OII) | October 2022 | 66.15% |
Avis Budget (CAR) | October 2022 | 54.34% |
Tidewater (TDW) | October 2022 | 50.67% |
Viking Therapeutics (VKTX) | October 2022 | 48.55% |
Norwegian Cruise Line (NCLH) | October 2022 | 46.23% |
Impinj (PI) | October 2022 | 42.95% |
Seadrill (SDRL) | October 2022 | 42.53% |
Patterson-UTI Energy (PTEN) | October 2022 | 42.13% |
Sylvamo (SLVM) | October 2022 | 41.64% |
Transocean (RIG) | October 2022 | 41.54% |
Enerpac Tool (EPAC) | October 2022 | 40.89% |
Solaris Energy Infrastructure (SEI) | October 2022 | 39.84% |
Genius Sports (GENI) | October 2022 | 39.3% |
Scholar Rock (SRRK) | October 2022 | 37.46% |
Dana (DAN) | October 2022 | 37.35% |
Gap (GAP) | October 2022 | 36.87% |
Modine Manufacturing (MOD) | October 2022 | 36.38% |
Olema Pharmaceuticals (OLMA) | October 2022 | 36.23% |
Kymera Therapeutics (KYMR) | October 2022 | 35.87% |
Caesars Entertainment (CZR) | October 2022 | 35.47% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
